Contains Nonbinding Recommendations
|
|
|
- Elaine Gray
- 10 years ago
- Views:
Transcription
1 Guidance for Industry and FDA Staff Laser Products Conformance with IEC and IEC ; Guidance for Industry and FDA Staff (Laser Notice No. 50) Document issued on June 24, 2007 This document supersedes Laser Products Conformance with IEC , Am. 2 and IEC ; Final Guidance for Industry and FDA (Laser Notice No. 50), July 26, For questions regarding this document contact Jerome Dennis, , [email protected]. U.S. Department of Health and Human Services Food and Drug Administration Center for Devices and Radiological Health Electronic Products Branch Division of Mammography Quality and Radiation Programs Office of Communication, Education, and Radiation Programs 1
2 Public Comment Preface Written comments and suggestions may be submitted at any time for Agency consideration to the Division of Dockets Management, Food and Drug Administration, 5630 Fishers Lane, Room 1061, (HFA-305), Rockville, MD, When submitting comments, please refer to the exact title of this guidance document. Comments may not be acted upon by the Agency until the document is next revised or updated. Additional Copies Additional copies are available from the Internet at: You may also send an request to to receive an electronic copy of the guidance or send a fax request to to receive a hard copy. Please use the document number (1346) to identify the guidance you are requesting. 2
3 Guidance for Industry and FDA Staff Guidance on Laser Products Conformance with IEC and IEC (Laser Notice No. 50) This guidance represents the Food and Drug Administration's (FDA's) current thinking on this topic. It does not create or confer any rights for or on any person and does not operate to bind FDA or the public. You can use an alternative approach if the approach satisfies the requirements of the applicable statutes and regulations. If you want to discuss an alternative approach, contact the FDA staff responsible for implementing this guidance. If you cannot identify the appropriate FDA staff, call the appropriate number listed on the title page of this guidance. Introduction This guidance describes the conditions under which laser product manufacturers may introduce into United States commerce laser products that comply with the IEC standards , as amended, and This guidance also describes additional requirements of the CDRH standard and alternate certification statements to be used with such products. Laser products for introduction into commerce in or imported into the United States must: Comply with 21 CFR and as applicable, Be certified and identified in accordance with 21 CFR and , and Be reported in accordance with 21 CFR CDRH has issued notices to laser product manufacturers and importers stating non-objection to: Lack of emission indicators or beam attenuators on Class II and Class IIIa systems, and Hazard warning labels as specified in IEC CDRH will not object to conformance with many sections of IEC , as amended, and 3
4 IEC as alternatives to comparable sections of 21 CFR and CDRH plans to amend federal regulations for laser products to reflect those sections of the IEC standards. CDRH is also listing sections of its standard that contain requirements to which manufacturers must conform. This action is appropriate because of the Center's intent to harmonize its requirements with many of those of the IEC standards. FDA's guidance documents, including this guidance, do not establish legally enforceable responsibilities. Instead, guidances describe the Agency's current thinking on a topic and should be viewed only as recommendations, unless specific regulatory or statutory requirements are cited. The use of the word should in Agency guidances means that something is suggested or recommended, but not required. The Least Burdensome Approach We believe we should consider the least burdensome approach in all areas of medical device and electronic product regulation. This guidance reflects our careful review of the relevant scientific and legal requirements and what we believe is the least burdensome way for you to comply with those requirements. However, if you believe that an alternative approach would be less burdensome, please contact us so we can consider your point of view. You may send your written comments to the contact person listed in the preface to this guidance or to the CDRH Ombudsman. Comprehensive information on CDRH's Ombudsman, including ways to contact him, can be found on the Internet at 1. Issue The Food and Drug Administration s (FDA) Center for Devices and Radiological Health (CDRH) intends to amend its standards for laser products at 21 CFR and to harmonize many of its requirements with those of the IEC and standards. Although CDRH began its amendment process in anticipation of the amendment of IEC , it is not yet ready to publish an amendment. CDRH has acknowledged the advantages of one set of criteria and requirements worldwide. Edition 1.2 of IEC was published in August, Edition 2 was published in March, Edition 2 of IEC was published in November, Edition 3 was published in May, As a result, manufacturers distributing products in both the U.S. and countries that require conformance with, or that recognize IEC , will have to evaluate the conformance of their products with this standard. This requires them to often change the hazard classification of their products. These manufacturers are requesting relief from CDRH so that they will have to comply with only one laser product radiation safety standard. 4
5 2. Guidance For what sections of 21 CFR can conformance with sections of IEC and be substituted? Effective immediately, and until the effective date(s) of any amendments of the Federal regulations affecting laser products, CDRH will not object to conformance with the comparable sections of IEC , Editions 1.2 or 2 or in lieu of conformance with the following sections of 21 CFR 1040: (b) Definitions (c)(1) Classification (d) Accessible emission limits (e) Tests for determination of compliance (f)(1) Protective housing (f)(2) Safety interlocks (f)(3) Remote Interlock connector (f)(4) Key control (f)(5) Laser radiation emission indicator (f)(6) Beam attenuator (f)(7) Location of controls (f)(8) Viewing optics (f)(9) Scanning safeguard (g) Labeling requirements (h)(1) User information (a) Medical laser products CDRH intends to harmonize the requirements of these sections with those of the IEC standards. Which applicable sections of 21 CFR are unaffected by this guidance? The following sections are unaffected. Laser products must conform to the following sections of the CDRH standards: Certification Identification Variances (a) Applicability (c)(2) Removable laser systems (f)(10) Manual reset mechanism (h)(2) Purchasing and servicing information (i) Modification of a certified product (b) Surveying, leveling and alignment laser products (c) Demonstration laser products CDRH intends to retain these requirements even if they differ from the IEC. They are either beyond the scope of the IEC standard, are sufficiently different, or are not normative and included as recommendations in the User s Guide section of the IEC standard. 5
6 What should manufacturers do in using this guidance? 1. Use the following modified statement of compliance on the certification label: Complies with FDA performance standards for laser products except for deviations pursuant to Laser Notice No. 50, dated (Insert date of this guidance.) or Complies with 21 CFR and except for deviations pursuant to Laser Notice No. 50, dated June 24, 2007 ; and 2. Submit product reports or supplemental reports to describe changes to products in accordance with this guidance. The effectiveness of this guidance will end on the effective date(s) of any amendments to the Federal regulations applicable to laser products under Chapter 1, Subchapter J of Title 21 of the Code of Federal Regulations. 3. Getting More Information You can get more information about our requirements for lasers from our electronic product radiation control web page at If you have questions about this guidance, contact, Office of Communication, Education, and Radiation Programs, Center for Devices and Radiological Health,, Fax: ( ) -, or [email protected]. 6
How To Exempt From Reporting And Recordkeeping Requirements For Tv And Computer Monitors With Cathode Ray Tubes
Guidance for Industry and FDA Staff Exemption from Certain Reporting and Recordkeeping Requirements for Television Receivers and Computer Monitors with Cathode Ray Tubes Document issued on October 20,
Guidance for Industry. Further Amendments to General Regulations of the Food and Drug Administration to Incorporate Tobacco Products
Guidance for Industry Further Amendments to General Regulations of the Food and Drug Administration to Incorporate Tobacco Products Small Entity Compliance Guide Written comments and suggestions may be
Medical Device Data Systems, Medical Image Storage Devices, and Medical Image Communications Devices
Medical Device Data Systems, Medical Image Storage Devices, and Medical Image Communications Devices Draft Guidance for Industry and Food and Drug Administration Staff DRAFT GUIDANCE This guidance document
Guidance for Industry and FDA Staff Tonometers - Premarket Notification [510(k)] Submissions
Guidance for Industry and FDA Staff Tonometers - Premarket Notification [510(k)] Submissions Document issued on: March 27, 2006 For questions regarding this document, contact Everette Beers, Ph.D. at 240-276-4200
Unique Device Identifier System: Frequently Asked Questions, Vol. 1 Guidance for Industry and Food and Drug Administration Staff
Unique Device Identifier System: Frequently Asked Questions, Vol. 1 Guidance for Industry and Food and Drug Administration Staff Document issued on August 20, 2014. On November 5, 2014 this document was
Guidance for Industry
Guidance for Industry Medication Guides Adding a Toll-Free Number for Reporting Adverse Events U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research
Guidance for Industry
Guidance for Industry FDA Export Certificates Submit comments and suggestions regarding this document at anytime to Dockets Management Branch (HFA-305), Food and Drug Administration, 5630 Fishers Lane,
Information Sheet Guidance For IRBs, Clinical Investigators, and Sponsors
Information Sheet Guidance For IRBs, Clinical Investigators, and Sponsors FDA Institutional Review Board Inspections Additional copies are available from: Office of Good Clinical Practice Office of Special
Guidance for Industry. 21 CFR Part 11; Electronic. Records; Electronic Signatures. Time Stamps
Guidance for Industry 21 CFR Part 11; Electronic Records; Electronic Signatures Time Stamps Draft Guidance This guidance document is being distributed for comment purposes only. Comments and suggestions
General Wellness: Policy for Low Risk Devices. Draft Guidance for Industry and Food and Drug Administration Staff
General Wellness: Policy for Low Risk Devices Draft Guidance for Industry and Food and Drug Administration Staff DRAFT GUIDANCE This guidance document is being distributed for comment purposes only. Document
In accordance with 21 CFR 1010.4(c) (l), this variance shall become effective on the date of this letter.
DEPARTMENT OF HEALTH 81 HUMAN SERVICES Public Health Service 5 5 2 1 00 fgy -5 fijsj 53 Food and Drug Administration 2098 Gaither Road Rockville MD 20850 Ref: FDA Docket No. OOV-1126 Accession No. OOA0401
How To Validate Software
General Principles of Software Validation; Final Guidance for Industry and FDA Staff Document issued on: January 11, 2002 This document supersedes the draft document, "General Principles of Software Validation,
Guidance for Industry
Guidance for Industry Providing Regulatory Submissions in Electronic Format Content of Labeling U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and
U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) March 2006 Compliance
Guidance for Industry Prescription Drug Marketing Act Donation of Prescription Drug Samples to Free Clinics U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation
Guidance for Industry
Guidance for Industry Electronic Source Data in Clinical Investigations DRAFT GUIDANCE This guidance document is being distributed for comment purposes only. Comments and suggestions regarding this draft
Document issued on: December 2, 2014. The draft of this document was issued on March 11, 2013. Contains Nonbinding Recommendations
Recommendations for Labeling Medical Products to Inform Users that the Product or Product Container is not Made with Natural Rubber Latex Guidance for Industry and Food and Drug Administration Staff Document
Refuse to Accept Policy for 510(k)s. Guidance for Industry and Food and Drug Administration Staff
Refuse to Accept Policy for 510(k)s Guidance for Industry and Food and Drug Administration Staff Document issued on: December 31, 2012 This document supersedes Center for Devices and Radiological Health
FINAL GUIDANCE. For questions on the content of this guidance, contact Advisory Committee Oversight and Management Staff, at 301-796-8220.
Guidance for the Public, FDA Advisory Committee Members, and FDA Staff: Public Availability of Advisory Committee Members' Financial Interest Information and Waivers FINAL GUIDANCE Comments and suggestions
Guidance for Industry Classifying Resubmissions in Response to Action Letters
Guidance for Industry Classifying Resubmissions in Response to Action Letters U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) Center
Guidance for Industry and Food and Drug Administration Staff
Requests for Feedback on Medical Device Submissions: The Pre-Submission Program and Meetings with Food and Drug Administration Staff Guidance for Industry and Food and Drug Administration Staff Document
October 28, 2015. Cavex Holland Bv Mr. Richard Woortman Manager Technical Services Fustweg 5 Haarlem, 2031CJ The NETHERLANDS
DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002 October 28, 2015 Cavex
Guidance for Sponsors, Institutional Review Boards, Clinical Investigators and FDA Staff
Guidance for Sponsors, Institutional Review Boards, Clinical Investigators and FDA Staff Guidance on Informed Consent for In Vitro Diagnostic Device Studies Using Leftover Human Specimens that are Not
May 7, 2015. Tactile Systems Technology Inc Daniel Chase V.P. Engineering & Operations 1331 Tyler St NE Minneapolis, Minnesota 55413
DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002 May 7, 2015 Tactile Systems Technology Inc Daniel
INTEL S SAFETY WARNING LABEL REQUIREMENTS
INTEL S SAFETY WARNING LABEL REQUIREMENTS INTRODUCTION: Direction is provided on Intel s Safety Warning Label requirements to ensure suppliers provide equipment with hazards identified and the safety precautions
February 20,200O. FDA Dockets Management Branch HFA305 FDA 4-62 5600 Fishers Lane Rockville, MD 20857
DESIGN GROUP f 9 5 9 00 NAR -I y1 :0$3 February 20,200O FDA Dockets Management Branch HFA305 FDA 4-62 5600 Fishers Lane Rockville, MD 20857 To whom it may concern, Attached is Lightspeed Design s initial
Information Sheet Guidance For IRBs, Clinical Investigators, and Sponsors
Information Sheet Guidance For IRBs, Clinical Investigators, and Sponsors Frequently Asked Questions About Medical Devices Additional copies are available from: Office of Good Clinical Practice Office
February 5, 2015. Dear Kristin Pabst,
DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002 February 5, 2015, Inc.
Laser Safety Requirements
Guidelines for Users of Honeywell s VCSEL Products NOTICE This report contains a summary of publicly available information relevant to the use of laser products manufactured or sold by Honeywell. These
Guidance for Industry
Guidance for Industry Major, Minor, and Telephone Amendments to Abbreviated New Drug Applications Comments and suggestions regarding this document should be submitted within 90 days of publication in the
Guidance for Industry and Investigators Safety Reporting Requirements for INDs and BA/BE Studies- Small Entity Compliance Guide
Guidance for Industry and Investigators Safety Reporting Requirements for INDs and BA/BE Studies- Small Entity Compliance Guide U.S. Department of Health and Human Services Center for Drug Evaluation and
Use of Electronic Health Record Data in Clinical Investigations
Use of Electronic Health Record Data in Clinical Investigations Guidance for Industry DRAFT GUIDANCE This guidance document is being distributed for comment purposes only. Comments and suggestions regarding
Guidance for Industry
Guidance for Industry Electronic Source Data in Clinical Investigations U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) Center for
Phoenix Thera-Lase Systems, LLC Ms. Diane Rutherford Ken Block Consulting 1201 Richardson Drive, Suite 280 Richardson, Texas 75080
DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration 10903 New Hampshire Avenue Document Control Center WO66-G609 Silver Spring, MD 20993-0002 Phoenix Thera-Lase Systems,
Guidance for Industry
Guidance for Industry Container and Closure System Integrity Testing in Lieu of Sterility Testing as a Component of the Stability Protocol for Sterile Products For questions on the content of the guidance,
Guidance for Industry
Guidance for Industry Toll-Free Number Labeling and Related Requirements for Over-the-Counter and Prescription Drugs Marketed With Approved Applications Small Entity Compliance Guide U.S. Department of
JUN 2 6 butt. EkoSonicTM Endovascular System with Rapid Pulse Modulation
KC6, IL(6/ SPECIAL 510(k) Notification EkoSonic TM Endovascular System JUN 2 6 butt Section 4. General Provisions 510(k) Summary Submitter's Name and Address: Contact Person: Classification Name: EKOS
Guidance for Industry. IRB Review of Stand-Alone HIPAA Authorizations Under FDA Regulations
Guidance for Industry IRB Review of Stand-Alone HIPAA Authorizations Under FDA Regulations FINAL This guidance is being distributed GUIDANCE for immediate implementation. FDA is issuing this guidance for
Guidance for Industry 180-Day Exclusivity When Multiple ANDAs Are Submitted on the Same Day
Guidance for Industry 180-Day Exclusivity When Multiple ANDAs Are Submitted on the Same Day U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research
U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) September 2009 OTC
Guidance for Industry Labeling of Nonprescription Human Drug Products Marketed Without an Approved Application as Required by the Dietary Supplement and Nonprescription Drug Consumer Protection Act: Questions
0 EC2 92011 V-,) 133 Lj9a
0 EC2 92011 V-,) 133 Lj9a Section 5: 5 1 0(k) Summar 5 10(K) SUMMARY FOR SOMATOM DEFINITION Flash (with Stellar Detector) Submitted by: Siemens Medical Solutions USA, Inc. 51 Valley Stream Parkway Malvern,
Guidance for Industry Computerized Systems Used in Clinical Investigations
Guidance for Industry Computerized Systems Used in Clinical Investigations U.S. Department of Health and Human Services Food and Drug Administration (FDA) Office of the Commissioner (OC) May 2007 Guidance
DRAFT GUIDANCE. This guidance document is being distributed for comment purposes only.
Guidance for Industry Format and Content of Proposed Risk Evaluation and Mitigation Strategies (REMS), REMS Assessments, and Proposed REMS Modifications DRAFT GUIDANCE This guidance document is being distributed
Recommended Warning for Overthe-Counter. Containing Drug Products and Labeling Statements Regarding Serious Skin Reactions
Recommended Warning for Overthe-Counter Acetaminophen- Containing Drug Products and Labeling Statements Regarding Serious Skin Reactions Guidance for Industry DRAFT GUIDANCE This guidance document is being
Risk Evaluation and Mitigation Strategies: Modifications and Revisions Guidance for Industry
Risk Evaluation and Mitigation Strategies: Modifications and Revisions Guidance for Industry The portion of this guidance document setting forth the submission procedures for risk evaluation and mitigation
Guidance for Industry. Required Warnings for Cigarette Packages and Advertisements
Guidance for Industry Required Warnings for Cigarette Packages and Advertisements Small Entity Compliance Guide Written comments and suggestions may be submitted at any time for Agency consideration to
Ultimate Concepts Inc.
MAR 2 3 2004 Ultimate Concepts Inc. 7835 South 1300 East Sandy, Utah 84094 Phone 800-682-3241 or 801-566-3214 SUMMARY Submitter's name: Address: Ultimate Concepts, Inc. 7835 South 1300 East Sandy, Utah
AW Server 510 (k) Summary of Safety and Effectiveness
SEP 2 2008 GE Medical Systems AW Server 510 (k) Summary of Safety and Effectiveness This 510(k) summary of safety and effectiveness information is submitted in accordance with the requirements of 21 CFR
GE Healthcare MAR 1 2013
K130155 Pagel1 of 2 GE Healthcare MAR 1 2013 510(k) Summary In accordance with 21 CFR 807.92 the following summary of information is provided: Submitter: Primary Contact Person: Secondary Contact Person:
) 1 1 > 1 FDA Docket No. 02H-0443 1 ) ) ) ) 1 1 ) 1 )
UNITED STATES OF AMERICA BEFORE THE FOOD AND DRUG ADMINISTRATION DEPARTMENT OF HEALTH AND HUMAN SERVICES In the matter of LAHAYE CENTER FOR ADVANCED EYE CARE OF LAFAYETTE, D/B/A LAHAYE TOTAL EYE CARE,
DEC 2 2 2005. The three components of the Axxent Electronic Brachytherapy System include the Controller, Balloon Applicators-BR and X-ray Source.
DEC 2 2 2005 Xoft, Inc. Fremont, California Premarket Notification March 31, 2005 II. 510(k) Summary A. Name of Device Trade name: AxxentTM Electronic Brachytherapy System Common name: X-Ray Radiation
Custom Device Exemption. Draft Guidance for Industry and Food and Drug Administration Staff
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 Custom Device Exemption Draft Guidance for Industry and Food and Drug Administration Staff DRAFT GUIDANCE This guidance
SECTION 5 BARDEX TEMPERATURE-SENSING FOLEY CATHETER 510(k) SUMMARY OF SAFETY AND EFFECTIVENESS INFORMATION
SECTION 5 510(k) SUMMARY OF SAFETY AND EFFECTIVENESS INFORMATION This 5 10(k) summary of safety and effectiveness information is being submitted in accordance with the requirements of SMDA 1990. A. SUBMITTER
DSCSA Implementation: Annual Reporting by Prescription Drug Wholesale Distributors and Third-Party Logistics Providers
DSCSA Implementation: Annual Reporting by Prescription Drug Wholesale Distributors and Third-Party Logistics Providers Guidance for Industry DRAFT GUIDANCE This guidance document is being distributed for
January 12, 2016. Dear Amy Yang:
DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002 January 12, 2016 Amy
Assay Migration Studies for In Vitro Diagnostic Devices Guidance for Industry and FDA Staff
Assay Migration Studies for In Vitro Diagnostic Devices Guidance for Industry and FDA Staff Document issued on: April 25, 2013 The draft of this document was issued on January 5, 2009. For questions regarding
Guidance for Industry. 21 CFR Part 11; Electronic Records; Electronic Signatures. Electronic Copies of Electronic Records
Guidance for Industry 21 CFR Part 11; Electronic Records; Electronic Signatures Electronic Copies of Electronic Records Draft Guidance This guidance document is being distributed for comment purposes only.
Guidance for Industry Tablet Scoring: Nomenclature, Labeling, and Data for Evaluation
Guidance for Industry Tablet Scoring: Nomenclature, Labeling, and Data for Evaluation DRAFT GUIDANCE This guidance document is being distributed for comment purposes only. Comments and suggestions regarding
Guidance for Industry
Guidance for Industry Charging for Investigational Drugs Under an IND Qs & As DRAFT GUIDANCE This guidance document is being distributed for comment purposes only. Comments and suggestions regarding this
Guidance for Industry
Reprinted from FDA s website by EAS Consulting Group, LLC Guidance for Industry Providing Regulatory Submissions in Electronic Format Standardized Study Data DRAFT GUIDANCE This guidance document is being
Guidance for IRBs, Clinical Investigators, and Sponsors. Considerations When Transferring Clinical Investigation Oversight to Another IRB
Guidance for IRBs, Clinical Investigators, and Sponsors Considerations When Transferring Clinical Investigation Oversight to Another IRB U.S. Department of Health and Human Services Food and Drug Administration
Determination of Regulatory Review Period for Purposes of Patent Extension; XARELTO
This document is scheduled to be published in the Federal Register on 05/29/2014 and available online at http://federalregister.gov/a/2014-12349, and on FDsys.gov 4160-01-P DEPARTMENT OF HEALTH AND HUMAN
Guidance for Industry Certification Process for Designated Medical Gases
Guidance for Industry Certification Process for Designated Medical Gases DRAFT GUIDANCE This guidance document is being distributed for comment purposes only. Comments and suggestions regarding this draft
Guidance for Industry
Guidance for Industry Fees-Exceed-the-Costs Waivers Under the Prescription Drug User Fee Act U.S. Department of Health and Human Services Office of Financial Management June 1999 User Fees Guidance for
sbchoi~kku.edu jeremy~sooil.com DANA Diabecare IlS Insulin Infusion pump Infusion pump Class II
510(k) Summary for DANA Diabecare IS SPONSOR SOOIL Development Co, Ltd. 196-1, Dogok-dong, Kangnam-gu Seoul 135-270 Korea 2 2007 Contact Person: Soo Bong Choi Telephone: 82-2-3463-0041 Fax: 82-2-3463-7077
Document issued on: May 11, 2005
Guidance for Industry and FDA Staff Guidance for the Content of Premarket Submissions for Software Contained in Medical Devices Document issued on: May 11, 2005 This document supersedes Guidance for the
DRAFT GUIDANCE. This guidance document is being distributed for comment purposes only. Document issued on: July 2015
Third-Party Auditor/Certification Body Accreditation for Food Safety Audits: Model Accreditation Standards Draft Guidance for Industry and Food and Drug Administration Staff DRAFT GUIDANCE This guidance
Guidance for Industry ANDA Submissions Amendments and Easily Correctable Deficiencies Under GDUFA
Guidance for Industry ANDA Submissions Amendments and Easily Correctable Deficiencies Under GDUFA DRAFT GUIDANCE This guidance document is being distributed for comment purposes only. Comments and suggestions
Rice University Laser Safety Manual
Rice University Laser Safety Manual Environmental Health and Safety MS 123 P.O. Box 1892 Houston, TX 77251-1892 December 2012 RICE UNIVERSITY 1 Introduction This manual is intended to provide the basic
MAR 23 2009. 510(k) SUMMARY OF SAFETY AND EFFECTIVENESS (21CFR 807.92) 1. DATE PREPARED: 4/21/2008
MAR 23 2009 510(k) SUMMARY OF SAFETY AND EFFECTIVENESS (21CFR 807.92) 1. DATE PREPARED: 4/21/2008 H. SUBMITTER: BRIT Systems, Inc. 1909 1Hi-Line Dr. Dallas, TX 75207 M~. CONTACT PERSON: Robert Munry VP
Guidance for Industry and FDA Staff. Class II Special Controls Guidance Document: Arrhythmia Detector and Alarm
Guidance for Industry and FDA Staff Class II Special Controls Guidance Document: Arrhythmia Detector and Alarm Document issued on: October 28, 2003 The draft of this document was issued on December 13,
kok1 UQ 510(k)J Device {Applicant 510(k) Summary (per 21 CFR 807.92(c)) OCT 2 7 2008 1. Applicant
kok1 UQ 510(k) Summary (per 21 CFR 807.92(c)) OCT 2 7 2008 1. Applicant Tech Avenue Ventures d/b/a MPowRx Health and Wellness Products Inc. #510 3553-31 St. NW Calgary, Alberta T2L 2K7 Canada Contact Person:
510(k) SUMMARY MANI Needle and Suture Pack MANI, Inc.
510(k) SUMMARY MANI Needle and Suture Pack MANI, Inc. This 51 0(k) summary of safety and effectiveness for the MANI Needle and Suture Pack (Poly(ethylene terephthalate)) is submitted in accordance with
General Principles of Software Validation; Final Guidance for Industry and FDA Staff
General Principles of Software Validation; Final Guidance for Industry and FDA Staff Document issued on: January 11, 2002 This document supersedes the draft document, "General Principles of Software Validation,
BMR ~131o-lvleccai Kesearcn Ltd.
BMR ~131o-lvleccai Kesearcn Ltd. Parkmnore Business Park West, Galway, Ireland Tel: +353 (0)91 774300 - Fax: +353 (0)91 774301 6 4& This summary is being submitted in accordance with the requirements of
MViAKIO. V.A hn2 ATTACHMENT I 610(K) SUMMARY. Submitter:
MViAKIO SURGICGAL CCWRP2 V.A hn2 ATTACHMENT I 610(K) SUMMARY Submitter: MAKO Surgical Corp. Address: 2555 Davie Road, Fort Lauderdale, FL, 33317 Phone number: 954-927-2044 x. 605 Fax number: 954-927-0446
51O(K) SUMMARY: V.A.C@ Therapy family of devices.
51O(K) SUMMARY: V.A.C@ Therapy family of devices. I. Name of Device: V.A.C.@ ATSTM, mini V.A.C.@, V.A.C. 8 FreedomTM 11. Classification Name: Powered Suction Pump 21 CFR 878.4780 III.510(k) Applicant:
Sunlamp Products; Proposed Amendment to Performance Standard. SUMMARY: The Food and Drug Administration (FDA or Agency) is proposing to amend the
This document is scheduled to be published in the Federal Register on 12/22/2015 and available online at http://federalregister.gov/a/2015-32023, and on FDsys.gov 4164-01-P DEPARTMENT OF HEALTH AND HUMAN
510(K) SUMMARY. 510(k) Number KOS'00-r
" iirtual Ports Virtsua Ports Virtual Ports Ltd. 510(K) SUMMARY 510(k) Number KOS'00-r MAR 2 12008 Applicant's Name: Contact Person: Trade Name: Common name: Classification: Predicate Devices: Device Description:
Determination of Regulatory Review Period for Purposes of Patent Extension;
This document is scheduled to be published in the Federal Register on 12/15/2015 and available online at http://federalregister.gov/a/2015-31400, and on FDsys.gov 4164-01-P DEPARTMENT OF HEALTH AND HUMAN
Guidance for Industry
#108 Guidance for Industry How to Register with the CVM Electronic Submission System To Submit Information in Electronic Format Using the FDA Electronic Submissions Gateway This version of the guidance
Guidance for Industry. 21 CFR Part 11; Electronic Records; Electronic Signatures. Maintenance of Electronic Records
Draft Guidance for Industry -- Not For Implementation Guidance for Industry 21 CFR Part 11; Electronic Records; Electronic Signatures Maintenance of Electronic Records Draft Guidance This guidance document
510(k) SUMMARY APR 2 9 2009. Date: 15 th December 2008
Traditional 510(k) COOK Sydney IVF Vitrification & Warming Media APR 2 9 2009 510(k) SUMMARY Date: 15 th December 2008 Submitted By: Ms Milica Talic QA/RA Manager Cook Australia 12 Electronics Street Brisbane
Brainreader ApS February 4, 2015 C/O Mette Munch QA Consultant Skagenvej 21 Egaa, 8250 DENMARK
DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002 Brainreader ApS February
Ad-tech Medical Instrument Corporation. Principal Consultant Quality & Regulatory Associates, LLC. 800 Levanger Lane. Stoughton, Wisconsin 53589
DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service March 4, 2016 Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002 Ad-tech
Guidance for Industry and FDA Staff Commercially Distributed Analyte Specific Reagents (ASRs): Frequently Asked Questions
Guidance for Industry and FDA Staff Commercially Distributed Analyte Specific Reagents (ASRs): Frequently Asked Questions Document issued on: September 14, 2007 The draft of this guidance document was
Guidance for Industry
Guidance for Industry Internet/Social Media Platforms: Correcting Independent Third-Party Misinformation About Prescription Drugs and Medical Devices DRAFT GUIDANCE This guidance document is being distributed
DICOM Grid, Inc. January 25, 2016. Senior Consultant Biologics Consulting Group, Inc. 400 N. Washington Street, Suite 100 ALEXANDRIA VA 22314
DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration 10903 New Hampshire Avenue Document Control Center WO66-G609 Silver Spring, MD 20993-0002 DICOM Grid, Inc. Senior
